Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Larazotide, a therapy known to treat celiac disease, shows promise as a safe treatment for multisystem inflammatory syndrome in children linked to COVID-19, enhancing recovery and symptom resolution.

Yonker is a co-inventor on a patent for zonulin antagonists to treat MIS-C, as are two other co-authors. Co-authors also ...

There have been lots of changes to COVID vaccine recommendations. Here is the current vaccine schedule for people 6 months to 65+ years old.

In a small trial, Mass General Brigham researchers found a drug designed to treat Celiac disease supported a more rapid return to normal activities for patients following COVID.

Bay Area researchers created a group of AI “scientists” that proposed a potential COVID treatment. They say the approach ...

COVID symptoms this summer look a lot like symptoms from earlier strains, such as fatigue, runny nose and a headache. “The COVID symptoms that I’m seeing in clinic aren’t any different this year than ...

Q: I wish I could go to a doctor who could outline a personalized plan for improving and protecting my health, but that’s ...

The interview with Dr Asad Khan on long Covid (Solidarity 747-748) highlights the contribution to the growth in mental ill-health of widespread long Covid, which affects hundreds of millions of ...

The condition known as long COVID may be more common than people think, according to a new study led by Oregon Health & Science University researchers.

These five blue-chip dividend stocks have had a tough 2025 but are solid long-term buys for growth and income investors.

Here are five high-yield dividend stocks that offer passive income and solid entry points that investors can buy and forget ...